. 2022 Mar 28;20(4):799–808. doi: 10.2174/1570159X19666210528155801
© 2022 Bentham Science Publishers
This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
Fig. (3).
Potential mechanisms of Poloxamer 188 in CNS disorders.